Showing 451-460 of 9128 results for "".
The Biggest Developments in Dermatology: Drs. Tsao and Friedlander Provide Updates at Maui Derm
https://practicaldermatology.com/issues/january-february-2025/the-biggest-developments-in-dermatology-drs-tsao-and-friedlander-provide-updates-at-maui-derm/32937/The development of new therapeutics for dermatologic conditions in recent years has been so prolific that Hensin Tsao, MD, PhD, adopted a “Maui Journal of Medicine” theme for his conference-opening presentation at the Maui Derm Hawaii 2025 meeting in Maui, Hawaii.Evaluation of Cosmetic Training in Dermatology Residency
https://practicaldermatology.com/youngmd-connect/resident-resource-center/evaluation-of-cosmetic-training-in-dermatology-residency/23670/Survey findings highlight the need to expand cosmetic training in US residency programs.Mechanism of Action Matters: A Review of New and Emerging Biologics
https://practicaldermatology.com/issues/supplements/mechanism-of-action-matters-a-review-of-new-and-emerging-biologics/23178/Thin Melanomas: When is SLN Biopsy Indicated?
https://practicaldermatology.com/topics/skin-cancer-photoprotection/thin-melanomas-when-is-sln-biopsy-indicated/20805/New research offers additional evidence that mitotic rate may have a role in clinical decision-making.The Gender Gap in Dermatology: Where Are We Now?
https://practicaldermatology.com/topics/general-topics/the-gender-gap-in-dermatology-where-are-we-now/20820/Despite advances, women are still not equally represented in academic dermatology or dermatology leadership.The Placebo and Nocebo Effects in Dermatology
https://practicaldermatology.com/columns/clinical-focus-1/the-placebo-and-nocebo-effects-in-dermatology/23559/Increasing evidence suggests that these effects—though not fully understood—may be harnessed for patient care.Cutaneous T-Cell Lymphoma: Mogamulizumab as a Novel Treatment for Refractory Mycosis Fungoides and Sezary Syndrome
https://practicaldermatology.com/youngmd-connect/resident-resource-center/Cutaneous-T-Cell-Lymphoma-Mogamulizumab-as-a-Novel-Treatment-for-Refractory-Mycosis-Fungoides-and-Sezary-Syndrome/23409/An overview of the diagnosis and prognosis of CTCL.Histiocytoses: A Review of the Most Recent Classification System
https://practicaldermatology.com/topics/skin-cancer-photoprotection/histiocytoses-a-review-of-the-most-recent-classification-system/20503/A look at the proposed new classification system, grouping the histiocytoses into five categories, with tabular summaries for differential diagnosis.Treating From Within: A Discussion with Dr. Elizabeth Geddes-Bruce
https://practicaldermatology.com/youngmd-connect/wrap-ups/treating-from-within-a-discussion-with-dr-elizabeth-geddes-bruce/27170/In this YoungMD Connect Wrap Up, Shawn Shih, MD, FAAD, a dermatologist practicing in New York City, summarized a special talk by Dr. Elizabeth Geddes-Bruce on integrative approaches to common dermatologic conditions and aesthetics.Reassessing Topical 5-Fluorouracil for AK Management
https://practicaldermatology.com/topics/practice-management/reassessing-topical-5-fluorouracil-for-ak-management/21021/New research highlights the beneficial role of this therapeutic mainstay, alone and in combination with lesion-directed treatment.